CURE spoke with Dr. Xiuning Le during the International Association for the Study of Lung Cancer (IASLC) 2025 World Conference on Lung Cancer.

Variation of Second Cancer Risk by Family History of Retinoblastoma Among Long-Term Survivors Aung Ko Win, Graham G. Giles, Ingrid Winship, Melissa C. Southey, John L. Hopper, and Mark A. Jenkins, The ...

In August 2025, the FDA approved various anti-cancer treatments across a range of disease types, such as colorectal, lung ...

A CRISPR system detects rare cancer mutations in blood with single-nucleotide precision, outperforming ddPCR through ...

High-Risk Merkel Cell Carcinoma of the Skin Treated With Synchronous Carboplatin/Etoposide and Radiation: A Trans-Tasman Radiation Oncology Group Study—TROG 96:07 Purpose: To determine the frequency ...

Recently, a collaborated research group from Hefei Institutes of Physical Science (HFIPS) of Chinese Academy of Sciences (CAS) and The Second Hospital of Anhui Medical University dissected, for the ...